ID: ALA3219977

Max Phase: Preclinical

Molecular Formula: C19H34OS

Molecular Weight: 310.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)=CCC/C(C)=C/CC/C(C)=C/CSC(C)(C)CO

Standard InChI:  InChI=1S/C19H34OS/c1-16(2)9-7-10-17(3)11-8-12-18(4)13-14-21-19(5,6)15-20/h9,11,13,20H,7-8,10,12,14-15H2,1-6H3/b17-11+,18-13+

Standard InChI Key:  BMFFGHJNOJGRSF-OUBUNXTGSA-N

Associated Targets(Human)

Isoprenylcysteine carboxyl methyltransferase 596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.55Molecular Weight (Monoisotopic): 310.2330AlogP: 5.91#Rotatable Bonds: 10
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.50CX LogD: 5.50
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.51Np Likeness Score: 1.20

References

1. Majmudar JD, Morrison-Logue A, Song J, Hrycyna CA, Gibbs RA.  (2012)  Identification of a novel nanomolar inhibitor of hIcmt via a carboxylate replacement approach,  (9): [10.1039/C2MD20108A]

Source